Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
B-Lot Company, Jan-Mar (1Q) Ordinary Profit Increases by 60%
3452 B-Lot Company Limited 【J-GAAP】
Earnings ReportB-Lot Company Limited <3452> [TSE Std] announced its financial results after the market closed on May 15th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) expanded 1.27 billion yen, an increase 59.8% compared to the same period last year. However, the progress rate toward the full-year plan of 6.25 billion yen was 20.4%, almost the same as the five-year average of 23.2%.
In the most recent three-month period, from January to March (1Q), the operating profit margin decreased from 28.1% in the same period last year to 26.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2023 | 6,898 | 1,329 | 1,172 | 818 | 42.0 | 46.7 | May 15, 2023 | J-GAAP |
| Jan - Mar, 2024 | 3,247 | 914 | 798 | 582 | 30.4 | 25.0 | May 15, 2024 | J-GAAP |
| Jan - Mar, 2025 | 5,539 | 1,449 | 1,275 | 818 | 42.7 | ー | May 15, 2025 | J-GAAP |
| YoY | +70.6% | +58.5% | +59.8% | +40.5% | +40.2% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2024 | 16,079 | 3,396 | 3,196 | 2,333 | 121.4 | 0 | Aug 14, 2024 | J-GAAP |
| Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Apr 14, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 23,510 | 5,498 | 4,945 | 3,297 | 171.1 | 51 | Feb 15, 2024 | J-GAAP |
| Dec, 2024 | 30,933 | 6,340 | 5,810 | 3,941 | 204.6 | 61 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 Guidance | ー | 7,020 | 6,250 | 4,300 | 231.3 | 70 | Apr 14, 2025 | J-GAAP |
| YoY | - | +10.7% | +7.6% | +9.1% | +13.1% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 3,247 | 914 | 798 | 582 | 30.4 | 28.1 | May 15, 2024 | J-GAAP |
| Apr - Jun, 2024 | 12,832 | 2,482 | 2,398 | 1,751 | 91.1 | 19.3 | Aug 14, 2024 | J-GAAP |
| Jul - Sep, 2024 | 11,592 | 3,231 | 3,104 | 2,115 | 109.7 | 27.9 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 3,262 | -287 | -490 | -507 | -26.3 | -8.8 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 5,539 | 1,449 | 1,275 | 818 | 42.7 | 26.2 | May 15, 2025 | J-GAAP |
| YoY | +70.6% | +58.5% | +59.8% | +40.5% | +40.2% |
Related Articles
MATSUMOTO YUSHI, 10% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
FRUTA FRUTA, 58% Increase in Ordinary Profit, Record High for The First Time in Eleven Years
SATO HOLDINGS, 9% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 1 yen
Kaizen Platform, Jan-Mar (1Q) Ordinary Profit Turns to Profit
INTERTRADE, First Half Net Income Turns to Loss, Jan-Mar Net Income Loss Widens
VISION INC, Jan-Mar (1Q) Ordinary Profit Decreases by 3%
NAKAMURAYA, 33% Decrease in Ordinary Profit for The Current Fiscal Year
FUJITA, 17% Increase in Ordinary Profit for The Current Fiscal Year, Resuming Dividends at 2 yen for the First Time in fourteen terms., This Fiscal Year to Increase Dividend by 1 yen
SEYFERT, Jan-Mar (1Q) Ordinary Profit Loss Widens
D.Western Therapeutics Institute, Jan-Mar (1Q) Ordinary Profit Loss Narrows